Sir,

We enjoy reading the recent report on 'Wilms' tumour and chemotherapeutic access'.\[[@ref1]\] Anyanwa *et al*. reported that 'an institutionalised approach can help to improve access to anti-cancer drugs, reduce the rate of loss to follow-up and thus improve outcome'.\[[@ref1]\] In fact, the problem of anticancer drug access can be seen in many developing countries. In a previous report by Uba and Chirdan, 'poor availability of cytotoxic drugs' is an important factor contributing to the poor outcome of disease in Nigeria.\[[@ref2]\] It is suggested that pre-operative combined chemotherapy is required for the better operative curative outcome of paediatric cases of Wilms' tumours.\[[@ref3]\] To manage the high cost of chemotherapy, some new studies show that metronomic chemotherapy can be the hope for the management of the problem.\[[@ref4]\]
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